Credits will not be given (by ECCMID) for Poster session and Integrated Symposia.

07

08

09

10

11

12

13

14

15

16

17

18

Capital Hall C

07:45 – 08:45

Meet-the-Expert

Facilitating antimicrobial drug development: opportunities …
Facilitating antimicrobial drug development: opportunities through the US NIH/NIAID and the EU research programmes

09:00 – 11:00

Official Symposium

Adaptation of P. aeruginosa to acute and chronic infections
  • J. Blazquez (Madrid, ES)
  • N. Hoiby (Copenhagen, DK)

11:30 – 12:30

Keynote Lecture

Nobel Laureate 2011 Keynote LecturePhylogenetic …
Nobel Laureate 2011 Keynote Lecture
Phylogenetic perspectives in innate immunity
  • J. Cohen (Brighton, GB)

14:30 – 15:30

Keynote Lecture

ESCMID Excellence Award lecture
  • G. Cornaglia (Verona, IT)

16:00 – 18:00

Official Symposium

Reemergence of gonococcal infections
  • C. Tang (London, GB)
  • P. Mastrantonio (Rome, IT)

Capital Hall D

07:45 – 08:45

Meet-the-Expert

Diagnosis of carbapenemase producers in Enterobacteriaceae

09:00 – 11:00

Official Symposium

Challenges in osteoarticular infections
  • B. Atkins (Oxford, GB)
  • A. Trampuz (Lausanne, CH)

11:30 – 12:30

Oral Session

Epidemiology of MRSA in various European countries
  • H. Goossens (Antwerp, NL)
  • S. Stefani (Catania, IT)

14:30 – 15:30

Official Symposium

The year in infectious diseases
  • H. Giamarellou (Athens, GR)

16:00 – 18:00

Official Symposium

Non-mammalian models of infection
  • N. Frimodt-Möller (Copenhagen, DK)
  • J.J. Ewbank (Marseille, FR)

Capital Suite E

07:45 – 08:45

Meet-the-Expert

Travel medicine - where is it going?

09:00 – 11:00

Official Symposium

Resistance to anti-Gram-positive agents in Europe
  • S. Stefani (Catania, IT)
  • W. Witte (Wernigerode, DE)

11:30 – 12:30

Oral Session

Pathogenesis of viral infections
  • D. von Laer (Innsbruck, AT)
  • F. Baldanti (Pavia, IT)

14:30 – 15:30

Oral session

Optimised pharmacotherapy for nosocomial and …
Optimised pharmacotherapy for nosocomial and healthcare-associated infection
  • W. Hope (Manchester, GB)
  • F. Pea (Udine, IT)

16:00 – 18:00

Oral session

Highlights of parasitic disease research
  • B. Evengard (Umeå, SE)
  • M.J. Alvarez-Martinez (Barcelona, ES)

Capital Suite F

07:45 – 08:45

Meet-the-Expert

Vaccine recommendations in immunocompromised patients

11:30 – 12:30

Official Symposium

Risk-based algorithms for antifungal use in ICU
  • P. Muñoz (Madrid, ES)
  • M. Sanguinetti (Rome, IT)

14:30 – 15:30

Keynote Lecture

Challenges in developing vaccines against malaria, HIV and …
Challenges in developing vaccines against malaria, HIV and HCV
  • E. Petersen (Aarhus, DK)

16:00 – 18:00

Astellas Pharma EU Symposium

Breaking the cycle of recurrent C. difficile infections
  • F. Barbut (Paris, FR)
  • F. Fitzpatrick (Dublin, IE)

09:00 – 11:00

Official Symposium

Of money and bugs: the impact of recession on infectious diseases
  • D.P. Lew (Geneva, CH)
  • G. Cornaglia (Verona, IT)

Capital Suite G

07:45 – 08:45

Meet-the-Expert

Chronic respiratory fungal disease

09:00 – 11:00

Official Symposium

Diagnosing fungal diseases: future perspectives
  • R. Barnes (Cardiff, GB)
  • M.C. Arendrup (Copenhagen, DK)

11:30 – 12:30

Official Symposium

Human papillomaviruses: recent advances
  • G. Palù (Padova, IT)
  • J. Breuer (London, GB)

14:30 – 15:30

Oral session

Antimicrobial resistance in the environment
  • C.M. Vandenbroucke-Grauls (Amsterdam, NL)
  • M. Webber (Birmingham, GB)

16:00 – 18:00

Official Symposium

Genetic predisposition to fungal infection
  • T. Calandra (Lausanne, CH)
  • A. Puel (Paris, FR)

Capital Suite H

07:45 – 08:45

Meet-the-Expert

Cost-efficient diagnosis of tuberculosis: culture, …
Cost-efficient diagnosis of tuberculosis: culture, molecular techniques and immunological markers

09:00 – 11:00

Gen-Probe Symposium

Trichomonas vaginalis - no longer a minor STD
  • C.A. Gaydos (Baltimore, US)
  • M. Unemo (Örebro, SE)

11:30 – 12:30

Oral session

Novel methods to diagnose infections
  • G. Lina (Lyon, FR)
  • L. Martinez-Martinez (Santander, ES)

14:30 – 15:30

Oral session

Considering pharmacodynamic effects in antifungal treatment …
Considering pharmacodynamic effects in antifungal treatment strategies
  • A.J. Ullmann (Würzburg, DE)
  • U. Theuretzbacher (Vienna, AT)

16:00 – 18:00

Curetis Symposium

Bacterial pneumonia and emerging antibiotic resistance
  • C. Ginocchio (New York, US)
  • K. Klugman (Atlanta, US)

Hall N11 A

07:45 – 08:45

Meet-the-Expert

Treatment of community-acquired pneumonia

09:00 – 11:00

GSK Symposium

Appropriate management of CA-RTIs- applying consensus principles for antibiotic therapy
  • J. Garau (Barcelona, ES)
  • R. Finch (Nottingham, GB)

11:30 – 12:30

Keynote Lecture

Efflux and resistance - from basics to clinics
  • L.J.V. Piddock (Birmingham, GB)

14:30 – 15:30

Keynote Lecture

Cell wall targets and antibiotic winners and losers - an …
Cell wall targets and antibiotic winners and losers - an ecological dilemma
  • R. Hakenbeck (Kaiserslautern, DE)

16:00 – 18:00

GSK Symposium

New perspectives on otitis media: implications of a multi‐pathogen environment
  • J. Van Eldere (Leuven, BE)
  • R. Dagan (Beer Sheva, IL)

Hall N11 B

07:45 – 08:45

Meet-the-Expert

EUCAST: frequently asked questions

09:00 – 11:00

Pfizer Symposium

Prevenar 13, the new generation
  • P. Durando (Genoa, IT)
  • P. Krizova (Prague, CZ)

11:30 – 12:30

Keynote Lecture

Adaptation of bacteria from the environmental lifestyle to …
Adaptation of bacteria from the environmental lifestyle to the lifestyle in chronic infections
  • J. Blazquez (Madrid, ES)

14:30 – 15:30

Official Symposium

Automated antimicrobial susceptibility testing systems; …
Automated antimicrobial susceptibility testing systems; blessing or curse? - PRO/CON debate
  • D. Brown (Petersborough, GB)
  • A. Tambic-Andrasevic (Zagreb, HR)

16:00 – 18:00

Pfizer Symposium

Smart Bugs: the MRSA nosocomial infection challenge with a focus on complicated skin and soft-tissue infection and …
Smart Bugs: the MRSA nosocomial infection challenge with a focus on complicated skin and soft-tissue infection and nosocomial pneumonia
  • J. Chastre (Paris, FR)
  • F. Gudiol Munte (Barcelona, ES)

Platinum Suite 1/2

09:00 – 11:00

Official Symposium

Sequencing viruses - what can it tell us
  • A.D.M.E. Osterhaus (Rotterdam, NL)
  • J. Breuer (London, GB)

11:30 – 12:30

Official Symposium

Is it important who you are when you get an infectious …
Is it important who you are when you get an infectious disease?
  • B. Evengard (Umea, SE)
  • N. Altintas (Izmir, TR)

14:30 – 15:30

Official Symposium

Patient participation and empowerment in infection control …
Patient participation and empowerment in infection control - PRO/CON debate
  • S.J. Harbarth (Geneva, CH)
  • H. Sax (Zurich, CH)

16:00 – 18:00

Official Symposium

Infection control beyond the hospital: do perspectives change?
  • M.A. Borg (Valletta, MT)
  • U. Frank (Heidelberg, DE)

Platinum Suite 3/4

09:00 – 11:00

Oral session

Tuberculosis; epidemiology, diagnosis and management
  • F. Drobniewski (London, GB)
  • C. Lange (Borstel, DE)

11:30 – 12:30

Oral session

Monitoring antibiotic prescriptions in primary care: what …
Monitoring antibiotic prescriptions in primary care: what world do we discover?
  • S.J. Harbarth (Geneva, CH)
  • D. Nathwani (Dundee, GB)

14:30 – 15:30

oral session

ICU infections
  • A. Agodi (Catania, ES)
  • C. Brun-Buisson (Créteil, FR)

16:00 – 18:00

Oral Session

Antibiotic resistance in bloodstream and tissue infections
  • P. Muñoz (Madrid, ES)
  • W. Hryniewicz (Warsaw, PL)

07

08

09

10

11

12

13

14

15

16

17

18